Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 1.5 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Israel - English - Ministry of Health

rafa laboratories ltd - mesalazine (5 - aminosalicylic acid) - granules prolonged release gastro resistant - mesalazine (5 - aminosalicylic acid) 3 g - mesalazine - for the treatment of acute episodes and the maintenance of remission of ulcerative colitis.

Ireland - English - HPRA (Health Products Regulatory Authority)

tillotts pharma gmbh - mesalazine - suppository - 1000 milligram(s) - mesalazine

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: triethyl citrate; iron oxide red; magnesium stearate; sodium starch glycollate type a; titanium dioxide; methacrylic acid copolymer; purified talc; hypromellose; silicon dioxide; macrogol 6000; carmellose sodium; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

sawai pharmaceutical co.,ltd. - mesalazine - reddish brown to brown tablet, major axis: 15.3 mm, minor axis: 7.0 mm, thickness: 5.3 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - mesalazine - white to pale yellowish white tablet with 1/2 split line on one side, diameter: 9.2mm, thickness: 5.0mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

towa pharmaceutical co., ltd. - mesalazine - white to pale yellowish white tablet with 1/2 split line on both sides, major axis: 18.7mm, minor axis: 7.2mm, thickness: 5.7mm